HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amyris Inks Deal For Third Clean Beauty Brand; Inter Parfums’ Third Quarter; Beauty News In Brief

Executive Summary

Amyris plans to launch new Rose Inc. cosmetics in the third quarter of 2021. “We believe cosmetics to be the next opportunity for us to transform to clean,” says Amyris CEO John Melo. News in brief.

You may also be interested in...

Amyris To Fuel Consumer Brands Momentum With Clean Hair-Care Launch

The California-based sustainable ingredients and clean beauty firm has teamed with hairdresser and television personality Jonathan Van Ness for a clean hair-care line, after net sales in its consumer brands business more than tripled in the fiscal 2020 third quarter, announced in November 2020.

Amyris Making Headway In Fermentation-Derived Cannabinoids; CBD Could Hit Market In Early 2020

Synthetic biology firm Amyris has shipped to partner Lavvan its first cannabinoid produced via genetically engineered yeast. While Amyris’ announcement does not identify the specific cannabinoid, Lavvan leadership indicated in March 2019 that fermentation-derived CBD would be first to market, representing potential purity and value benefits compared with CBD extracted from the cannabis plant.

Beautycounter-Led Coalition Lobbies For Tighter Cosmetics Regulations

The beauty industry do-gooder returned to Washington Sept. 12 with 15 other brands in tow, pressing lawmakers for a hearing on the proposed Personal Care Products Safety Act.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts